CASEIN DERIVED PEPTIDES AND USES THEREOF IN THERAPY

Details for Australian Patent Application No. 2002324323 (hide)

Event Publications

16 January 2003 Complete Application Filed

Priority application(s): 09/942,121 30.08.01 US

5 June 2003 Application Open to Public Inspection

Published as AU-A-2002324323

6 May 2004 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 29 Mar 2004

28 September 2006 Assignment before Grant

Chay 13 Medical Research Group N.V. The application has been assigned to Peptera Parmaceuticals Ltd.

19 October 2006 Corrigenda

Assignments Before Grant, Section 113 - 2002 Under the name Peptera Parmaceuticals, Application No. 2002324323, under INID (71), correct to read Peptera Pharmaceuticals

14 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.